Sponsor pipeline

Telix Pharmaceuticals (Innovations) Pty Ltd clinical trial pipeline

Get alerts when Telix Pharmaceuticals (Innovations) Pty Ltd's trials change

1 active trials 1 recruiting 1 disease areas 2 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-08-28

What changed in the last 30 days

2026-08-15
Primary completion pushed: 2026-03 → 2027-10
Completion pushed: 2026-08 → 2027-12
NCT06537596 89Zr-olaratumab Dosimetry in Participants With PDGFR Alpha Positive Solid Tumours and… · Phase 1

Active trials by phase

Phase 1
1

Active trials

NCT IDTitleConditionStatusUpdated
Phase 1
NCT06537596 89Zr-olaratumab Dosimetry in Participants With PDGFR Alpha Positive Solid Tumours and… Soft Tissue Sarcoma Recruiting 2026-08-14

Disease areas by active trials

Sarcoma (1)

Get alerts when Telix Pharmaceuticals (Innovations) Pty Ltd's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free